Form 4 for MGNX MACROGENICS INC
Accepted 2021-07-20 00:00:00 ET · period of report 2021-07-16 · accession 0001125345-21-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-20 | 2021-07-16 | MGNX | Spitznagel Thomas | SVP, BPD, Manufacturing | S - Sale+OE | $25.01 | -5,000 | 0 | -100% | -$125.1K |
| D | 2021-07-20 | 2021-07-16 | MGNX | Spitznagel Thomas | SVP, BPD, Manufacturing | M - OptEx | $7.51 | +5,000 | 5,000 | New | +$37.5K |
| D | 2021-07-20 | 2021-07-16 | MGNX | Spitznagel Thomas | SVP, BPD, Manufacturing | M - OptEx | $7.51 | -5,000 | 37.1K | -12% | -$37.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-16 | S | D | 5,000 | $25.01 | 0 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $25.00 to $25.04. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2021-07-16 | M | A | 5,000 | $7.51 | 5,000 | D | — | — | |
| 3 | Derivative | Employee stock option (right to buy) | 2021-07-16 | M | D | 5,000 | $7.51 | 37,147 | D | $7.51 · 2014-03-18 to 2023-09-17 | 5,000 Common Stock | (F3) 12.5% of the shares underlying the grant become (or became) exercisable on the date reflected and an additional 6.25% of the shares underlying the grant become (or became) exercisable on the first day of each three-month period thereafter. |